Patents

US 7816490 B2: Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases

Granted
2010-10-19
Filed
2008-10-28 application 12260049
Type
Utility · 18 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Isolated peptide fragments of the conserved regulatory domain of NFAT protein capable of inhibiting protein-protein interaction between calcineurin and NFAT, or a biologically active analog thereof are described. Isolated polynucleotides and gene therapy vectors encoding such peptide fragments are also described. In addition, methods for treating immune-related diseases or conditions and methods for high throughput screening of candidate agents are described. Pharmaceutical compositions are also provided.

Source: PVGPATDIS, file of 2026-04-10 (ipg101019.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Immune Disease Institute 8 patentsUS company or organizationBoston, MAImmune Disease Institute Inc Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Patrick HoganCambridge, MA8PVGPATDIS, file of 2026-04-10
Anjana RaoCambridge, MA32PVGPATDIS, file of 2026-04-10
Jose AramburuBoston, MA1PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K5/101PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K38/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2010-02-23Correction
Corrective assignment to correct the name of the receiving party recorded march 27, 2009, from the center for blood research to center for blood research, inc. previously recorded on reel 022459 frame 0960. assignor(s) hereby confirms the patri
ARAMBURU, JOSE signed 1999-06-15
HOGAN, PATRICK G. signed 1999-06-15
RAO, ANJANA signed 1999-06-15
CENTER FOR BLOOD RESEARCH, INC. BOSTON, MA23977/945ECORSEXC, file of 2026-09-25
2009-12-11Name change
Change of name
THE CBR INSTITUTE FOR BIOMEDICAL RESEARCH, INC. signed 2007-06-05IMMUNE DISEASE INSTITUTE, INC. BOSTON, MA23641/408ECORSEXC, file of 2026-09-25
2009-04-01Name change
Change of name
CENTER FOR BLOOD RESEARCH, INC. signed 2003-08-12THE CBR INSTITUTE FOR BIOMEDICAL RESEARCH, INC. BOSTON, MA22481/450ECORSEXC, file of 2026-09-25
2009-03-27Assignment
Assignment of assignor's interest
ARAMBURU, JOSE signed 1999-06-15
HOGAN, PATRICK G. signed 1999-06-15
RAO, ANJANA signed 1999-06-15
THE CENTER FOR BLOOD RESEARCH BOSTON, MA22459/960ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.